Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on February 10, 2015. The filing details the consummation of a fourth closing under a Unit Purchase Agreement dated December 19, 2014, involving the sale of unregistered equity securities to accredited investors.
Key Financial Metrics and Transaction Details
The filing reports a specific capital raise event rather than standard operating financial metrics such as revenue or profit.
- Fourth Closing Proceeds: $842,500 raised on February 10, 2015.
- Securities Issued in Fourth Closing: 337,000 shares of Common Stock, "A" Warrants to purchase 337,000 shares (exercise price $2.50), and "B" Warrants to purchase 168,500 shares (exercise price $3.75).
- Total Aggregate Proceeds (All Closings): $2,425,600 (combining the Fourth Closing with three prior closings).
- Total Securities Issued (All Closings): 970,240 shares of Common Stock, "A" Warrants for 970,240 shares, and "B" Warrants for 485,120 shares.
The filing text does not provide clear values for revenue, operating profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the increase in outstanding equity and warrant obligations resulting from the Fourth Closing. This transaction increased the total capital raised under the Purchase Agreement from $1,583,100 (after the third closing) to $2,425,600.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure that the securities were sold unregistered under Section 4(a)(2) and Regulation D (Rule 506) of the Securities Act. The full text of the Purchase Agreement, Investor Warrants, and Registration Rights Agreement is referenced as an exhibit to the upcoming Form 10-K for the fiscal year ended December 31, 2014.
Investor Verification Checklist
- Verify the total number of outstanding shares and warrants post-issuance to assess dilution.
- Review the full text of the Unit Purchase Agreement and Registration Rights Agreement in the upcoming Form 10-K for restrictive covenants.
- Confirm the company's current cash position and burn rate to determine how long the $2.4 million in raised capital will sustain operations.
- Check for any subsequent filings regarding the exercise of the "A" and "B" Warrants.